This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

Medication-Assisted Treatment – Prescription Drug and Opioid Addiction (MAT-PDOA)

Link

https://www.samhsa.gov/grants/grant-announcements/ti-23-001

Additional Links

Notice of Funding Opportunity (Grants.gov)

Deadline

Application Deadline: Mar 7, 2023

Sponsor

Substance Abuse and Mental Health Services Administration (SAMHSA)

Purpose

Offers funding to states, nonprofits, American Indian and Alaska Native tribes, and tribal organizations to expand access to medications for opioid use disorder (MOUD). The desired program outcomes are to decrease illicit opioid drug use and prescription opioid misuse and increase the number of individuals with opioid use disorder (OUD) receiving MOUD, including those from racial, ethnic, sexual, and gender minority communities.

Proposals must implement the following required activities:

  • Provide MOUD using at least one of the medications approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of OUD in combination with comprehensive psychosocial services, counseling, behavioral therapies, recovery support services (RSS), and other clinically appropriate services.
  • Conduct an appropriate clinical assessment to establish the diagnosis and severity level of OUD, identify a recommended level of care, and develop an individualized treatment and recovery plan.
  • Check the state, county, or local prescription drug monitoring program (PDMP), where available, for each new patient admission in compliance with any relevant state rules or regulations.
  • Conduct screening and assessment for co-occurring substance use and mental disorders and the delivery or coordination of any services determined to be necessary for the individual patient to achieve and sustain recovery.
  • Develop outreach and engagement strategies to increase access to MOUD for diverse populations at risk for OUD and monitor inequitable access to different medications across these populations.
  • Ensure all applicable practitioners working on the project obtain any federal, state, or other required training on substance use disorder (SUD) and/or OUD for the prescribing of buprenorphine.
  • Build funding mechanisms and service delivery models with rural and resource-limited counties and municipalities, organizations such as health plans, integrated health systems, universities, hospitals, including emergency departments, clinics, community based organizations, law enforcement, community recovery organizations, faith-based organizations, and/or other local coalitions in order to provide a robust suite of treatment and RSS that effectively identify, engage, and retain individuals in OUD treatment and facilitate long-term recovery.
  • Use telehealth services, or other innovative interventions, to reach, engage, and retain patients in treatment.
  • Provide RSS, including peer recovery support services and culturally specific organizations, designed to improve access to and retention in MAT and facilitate long-term recovery.
  • Support harm reduction services, education, and supplies for individual organizations or in collaboration with community-based organizations.

Funds may also be used for program infrastructure development activities, including developing partnerships with providers, workforce development, training, and policy development, if needed, to implement proposed services.

Amount of Funding

Award ceiling: $750,000 per year
Project period: Up to 5 years
Estimated number of awards: 24
Estimated total program funding: $18,200,000

At least $9,500,000 will be awarded to up to 13 federally recognized American Indian/Alaska Native (AI/AN) tribes and tribal organizations.

Who Can Apply

Eligible applicants include:

  • States and territories
  • Political subdivisions of states
  • Indian tribes
  • Tribal organizations
  • Health facilities
  • Programs operated by or in accordance with a contract or award with the Indian Health Service (IHS)
  • Other public or private non-profit entities

Additional provision of service requirements include:

  • A provider organization for SUD treatment services appropriate to the grant must be involved in the proposed project. The provider may be the applicant or another organization committed to the project. More than one provider organization may be involved.
  • Each mental health/SUD treatment provider organization must have at least 2 years experience providing relevant services.
  • Each mental health/SUD treatment provider organization must comply with all applicable local, city, county, and state licensing, accreditation, and certification requirements, as of the due date of the application.

Grantees that received a Medication-Assisted Treatment – Prescription Drug and Opioid Addiction (MAT-PDOA) award under announcement numbers TI-21-006 in fiscal year (FY) 2021 or TI-22-013 in FY 2022 are not eligible to apply for this funding opportunity.

Geographic Coverage

Nationwide

What This Program Funds

New Program • Operating Costs and Staffing • Training Providers

Application Process

Application instructions, requirements, and other information can be found in the funding announcement.

Contact

For programmatic or technical questions:
Fred Bamfo
240-276-2423
mat-pdoa-c@samhsa.hhs.gov

For grants management or budget questions:
240-276-1400
FOACSAT@samhsa.hhs.gov

For grant review process and application status questions:
Emily Chan
240-276-2446
emily.chan@samhsa.hhs.gov

Rural Awards

Past awards communities received in fiscal year 2023 can be found on the program website.

Rural communities who have received funding include:

  • Ponca Tribe of Nebraska was awarded funds to implement the Ponca Health Services Medication-Assisted Treatment program to provide whole-person, culturally appropriate substance use services, including medication-assisted treatment, an outpatient treatment program, and recovery support services.
  • Tahlequah Hospital Authority in Oklahoma used funds to develop the Northeastern OK Medication Assisted Treatment (MAT) program that will utilize a hub-and-spoke model to increase access to MAT, mental health, and recovery services for rural, tribal populations in a 5-county area in northeastern Oklahoma.
  • Three Affiliated tribes (Mandan, Hidatsa, & Arikara Nation) in North Dakota received an award to establish a MAT-PDOA model of care throughout the Elbowoods Memorial Health Care System which will increase access to MAT for tribal members, develop referral processes from primary care providers, use case management to support MAT patients, and help enroll clients in private, state, and/or federal health insurance programs.

Topics This Program Addresses

American Indians, Alaska Natives, and Native Hawaiians • Harm Reduction • Healthcare Workforce • Medication-Assisted Treatment (MAT) • Opioids • Recovery • Substance Use Disorder • Teleservices and Technology • Treatment